Monophasic EAU following an attack by anti-SAg antibodies may be a result of a complete loss of ocular epithelial regenerative capacity, on the other hand, a remitting-relapsing disease following an autoimmune attack by anti-IRBP antibodies may be a consequence of a partial loss of this capacity. Here, RBP3 is linked to disease recurrence.